Observational studyPituitary2014

Lanreotide extended-release aqueous-gel formulation, injected by patient, partner or healthcare provider in patients with acromegaly in the United States: 1-year data from the SODA registry.

Roberto Salvatori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.